Author Question: The phenomena of opting-out gets its name from a 2003 article in the New York Times by Lisa Belkin ... (Read 80 times)

go.lag

  • Hero Member
  • *****
  • Posts: 667
The phenomena of opting-out gets its name from a 2003 article in the New York Times by Lisa Belkin titled:
 
  a. The Opt-Out Revolution
  b. Choosing to Opt-Out
  c. Opting-out: An American Revolution
  d. Motherhood Pulls: Opting Out

Question 2

Bernard, who is writing a paper on marriage and compatibility, believes that people with different personalities and needsare far more likely to attract and be suitable for each other.
 
  Which of the following statements, if true, is likely to weaken Bernard's belief?
  A) Romances tend to fizzle if a person's family members disapprove of the relationship.
  B) Couples with contrasting personalities are likely to adapt to each other's likes and dislikes.
  C) The opposites attract theory applies primarily to long-term relationships.
  D) With time, romantic attraction diminishes when partners have conflicting interests.



ebonylittles

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

a

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library